跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL
Approved
STANDARD
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL
Bayer Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 8, 2021
Approval ID
5587a6350f1c2125
Company
Bayer Ag
Type
Standard
Approval Details
Approval Id
5587a6350f1c2125
Drug Cima Aemps Name
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL
Register Number
108472050
Holder Company Name
Bayer Ag
Marketing Company Name
Bayer Hispania S.L.
Holder Company Detail Path
/organization/bayer-ag
Authorization Date
2021-02-08
Dosage Form
GRANULADO PARA SUSPENSIÓN ORAL
Dose
1 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Bayer Ag
Company Detail Path
/organization/bayer-ag
Company Information
Pharmaceutical Company Name
BAYER AG
Name En
Bayer AG
Country Name
Germany
City Name
Leverkusen
Address
Leverkusen, North Rhine-Westphalia, Germany
Website
https://www.bayer.com
Active Ingredients
RIVAROXABAN
51,7 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 8, 2021
Approval ID
5587a6350f1c2125
Type
Standard
Back to CIMA-AEMPS Approvals
